You are leaving HealthInsite
The HealthInsite information partner page you have requested
High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
(Publisher: John Wiley and Sons, Ltd. for The Cochrane Collaboration)
may contain links to websites which have not been reviewed by HealthInsite's Editorial Team.
